SEC Form 4 · accession 0001179110-15-004891
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katherine C. Doyle
Officer — Senior Vice President
Period of report
Oct 31, 2013
Accepted (ET)
Mar 13, 2015 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Oct 31, 2013 | P | 102 | $36.708 | A | 43,429 | D | |
| Common shares without par valueF1 | Dec 3, 2013 | P | 4 | $37.50 | A | 43,433 | D | |
| Common shares without par value | Feb 3, 2014 | S | 1 | $35.93 | D | 43,432 | D | |
| Common shares without par value | Mar 14, 2014 | P | 52 | $39.106 | A | 43,484 | D | |
| Common shares without par value | Apr 15, 2014 | S | 10 | $37.582 | D | 43,474 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Purchase was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 200 shares of Abbott common shares at a price of $39.015 per share (including transaction costs), or $38.999 per share (excluding transaction costs), which was reported on March 4, 2014. The reporting person has paid to Abbott $239.70, representing the full amount of the profit realized in connection with these transactions, less transaction costs.